Novo Nordisk seeks FDA approval for once-weekly Semaglutide to treat Type 2 Diabetes

2016-12-06 10:21:01

Novo Nordisk has submitted a New Drug Application to the US FDA for semaglutide, a glucagon-like peptide-1 (GLP-1) analog administered once-weekly, for the treatment of adults with type 2 diabetes.BY TEAM ABLENovo Nordisk has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for semaglutide, a glucagon-like peptide-1 (GLP-1) analog administered once-weekly, for th

Read more

Merck expands distribution agreement with Roche

2016-12-06 10:19:41

Merck will be the exclusive supplier of novel enzymes for polymerase chain reaction (PCR) and quantitative real-time PCR, for all countries except the US, Brazil and JapanBy Team ABLEMerck announced expansion of its distribution alliance with Roche to include the polymerase chain reaction (PCR) and quantitative real-time PCR (qPCR) enzyme products of Kapa Biosystems, a company acquired by Roche in

Read more

Science and Technology for Specially Abled Persons’ is the theme for National Science Day 2017

2016-12-05 08:40:40

The Department of Science & Technology (DST) under the Ministry of Science & Technology has selected the theme of \'Science and Technology for Specially Abled Persons’ for the National Science Day, 2017. February 28 is observed as the National Science Day.By Team ABLEIn a letter to the UGC, DST has asked the universities to ensure organization of National Science Day on 28th February, 20

Read more

On World AIDS Day, Health Minister J P Nadda appeals civilians to take a vow to end HIV/AIDS by 2030

2016-12-05 08:35:01

On the occasion of World AIDS Day, 2016 organized by the National AIDS Control Organisation (NACO), Ministry of Health and Family Welfare, Union Minister J P Nadda highlighted the efforts and strategies to end HIV/AIDS epidemic by 2030By Team ABLE“Our concerted efforts and strategies have been able to see a success story of India. We can now safely say that we can end the HIV/AIDS epidemic by 20

Read more

ICMR, ICAR collaborate to exploit research expertise on zoonoses, anti-microbial resistance

2016-12-05 08:29:11

The MoU, signed by Dr Soumya Swaminathan, ICMR and Dr Trilochan Mohapatra, ICAR, is expected to strengthen ties between the two organizations in the area of zoonoses, anti-microbial resistance, nutrition and pesticide residuesBy Team ABLEIndian Council of Medical Research (ICMR) signed a MoU with Indian Council of Agricultural Research (ICAR) for cooperation in the area of zoonoses, anti-microbial

Read more

Sun Pharma to acquire Russian pharma company Biosintez

2016-12-05 08:16:07

With the acquisition, Sun Pharma intends to step up local manufacturing capability in Russian market By Team ABLESun Pharma has announced the execution of definitive agreements by its wholly-owned subsidiary, for the acquisition of 85.1% of JSC Biosintez, a Russian pharmaceutical company engaged in manufacture and marketing of pharmaceutical products in Russia and CIS region. The equity considerat

Read more

Biocon\'s Diabetes Education Initiative for Medical Practitioners receives Award of Recognition from Research Society for the Study of Diabetes in India

2016-12-05 08:11:05

As a part of its social responsibility, Biocon had introduced ABIDE, a diabetes education initiative for medical practitioners in the year 2012, which has been conferred with the \'Award of Recognition\' by the Research Society for the Study of Diabetes in India (RSSDI)By Team ABLEAsia\'s premier biopharmaceuticals enterprise Biocon has been engaging with diverse stakeholders to educate them on ef

Read more

First new HIV vaccine efficacy study begins in South Africa

2016-12-05 08:05:26

The study, called HVTN 702, involves a new version of the only HIV vaccine candidate ever shown to provide some protection against the virus.By Team ABLEThe first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. The study, called HVTN 702, involves a new version of the only

Read more

DBT calls for Ramalingaswami Re-Entry Fellowship for skilled Indian National researchers working overseas

2016-11-28 11:54:28

The Department of Biotechnology has called for applications under the Ramalingaswami Re-Entry Fellowship for skilled Indian National researchers working overseas to pursue their R&D interests in Indian institutions.By Team ABLEIn a new announcement made by the Department of Biotechnology, applications are invited from Indian nationals working in overseas research institutions for the Ramalings

Read more

GSK initiates phase III development program for anemia drug, daprodustat

2016-11-28 11:51:34

GlaxoSmithKline has announced the start of a phase III development program investigating daprodustat as a treatment for anemia associated with chronic kidney disease (CKD)By Team ABLEPharmaceutical and healthcare giant GlaxoSmithKline recently announced the start of a phase III development program investigating daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), a

Read more